Natco Pharma Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Dec '24
Sep '24
Jun '24
Mar '24
Dec '23
Total Qtr Revenue cr
651.10
1,434.90
1,410.70
1,110.30
795.60
Other Income Qtr Cr176.3063.8048.1042.0037.00
Operating Revenues Qtr474.801,371.101,362.601,068.30758.60

*All values are in Cr.

Operating Expenses Qtr
436.00
566.80
557.80
571.00
490.50
Operating Profit Qtr
38.80
804.30
804.80
497.30
268.10
EBIDT Qtr Cr
215.10
868.10
852.90
539.30
305.10
Depreciation Qtr
47.00
45.80
44.10
55.50
44.20
Net Profit Qtr
133.00
677.30
668.50
386.30
212.70
Basic EPS Qtr
7.43
37.81
37.32
21.56
11.88
Open Demat Account
+91 -

personImage
Open Demat Account
+91 -